Purpose: To assess the current use of drug-eluting devices for peripheral arterial disease (PAD) among interventional radiologists following the controversy caused by the 2018 meta-analysis suggesting an increased mortality risk for paclitaxel-eluting devices.
Methods: An anonymous survey was sent to 7035 CIRSE members via email; only complete responses were included and statistically analysed.
Results: Three hundred and seven members (4.